Eli Lilly inks pacts for COVID-19 drug Baricitinib with Torrent Pharma, Dr Reddy's and MSN Labs

The drug Baricitinib will be used in combination with Remdesivir for the treatment of patients requiring supplemental oxygen, invasive mechanical ventilation, Eli Lilly and Company said in a statement

|May 13, 2021, 20:35:30 IST

New Delhi: Drug firm Eli Lilly and Company on Thursday said it has inked voluntary licensing agreements with three Indian drug firms – Torrent Pharmaceuticals, Dr Reddy's and MSN Laboratories – to expedite the availability of Baricitinib for treatment of COVID-19 patients in India.The company has issued additional royalty-free, non-exclusive voluntary licenses to Dr Reddy's, MSN Laboratories, and Torrent Pharmaceuticals, who will be collaborating with Lilly to accelerate and expand the availability of Baricitinib in India, Eli Lilly and Company said in a statement."These three additional voluntary licensing agreements will ensure high-quality manufacturing and accessibility of Baricitinib during this pandemic improving the local treatment options available to positively impact the lives of people who are currently battling COVID-19 in India," it added.The company on Monday had announced signing voluntary licensing agreements with Sun Pharma, Cipla and Lupin.Eli Lilly and Company has received permission for restricted emergency use by the Central Drugs Standard Control Organization (CDSCO), for Baricitinib to be used in combination with Remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalised adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation, the statement said."Lilly is committed to supporting India in this healthcare challenge through our innovative and effective portfolio of breakthrough medicines," Luca Visini, Managing Director, India Subcontinent, Lilly India said.This is in addition to the donations being offered by Lilly to the Indian government, he added."We will continue to explore other possible initiatives to support patients and the healthcare system in India, Visini said.Meanwhile, Eli Lilly and Company continue to engage in active dialogue with the regulatory authorities and government in India to donate its anti-COVID-19 treatments, including neutralising antibodies, the statement said.

10,000 steps a day is not enough: Top doctor explains the role of timing

Walking 10,000 steps a day is beneficial, but experts say timing matters. Short walks after meals and breaking up long periods of sitting may be more effective for blood sugar control and overall metabolic health

3 min read

What happens when you stop drinking tea for 30 days? Doctor explains the effects

Thinking of quitting tea for a month? Experts explain how cutting out caffeine can affect your body, from withdrawal symptoms in the first week to better sleep and improved iron absorption over time.

2 min read

Stroke is rising among young adults. Doctor explains why it's happening and what you must do

Stroke is increasingly affecting adults in their 30s, 40s and 50s. Experts say unhealthy lifestyles, undiagnosed high blood pressure and delayed treatment are driving the rise in younger stroke cases

3 min read

Stroke in young adults, silent symptoms and late diagnosis: India's growing brain health challenge

Neurologists warn that stroke is increasingly affecting people in their 30s and 40s, while many brain disorders progress silently before symptoms appear. They say early diagnosis, timely referrals and healthier lifestyles are key to reducing India's growing neurological disease burden.

5 min read

Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs

Brain tumours are frequently mistaken for common headaches, stress or age-related cognitive changes. Doctors say recognising warning signs early and adopting a brain-healthy lifestyle can improve outcomes and reduce the risk of long-term neurological complications.